His main research concerns Internal medicine, Surgery, Cohort study, Risk factor and Immunology. His Internal medicine research incorporates elements of Placebo and Endocrinology. His Placebo study integrates concerns from other disciplines, such as Gynecology and Randomized controlled trial.
His Surgery research incorporates themes from Odds ratio, Albuminuria, General surgery and Cohort. His Immunology study incorporates themes from Acquired immunodeficiency syndrome, Allele and Virology. His Hazard ratio study also includes
Eric Vittinghoff spends much of his time researching Internal medicine, Cardiology, Cohort, Confidence interval and Randomized controlled trial. His work deals with themes such as Endocrinology and Surgery, which intersect with Internal medicine. Eric Vittinghoff is studying Prospective cohort study, which is a component of Surgery.
His research combines Cohort study and Cohort. His Randomized controlled trial research focuses on Placebo and how it relates to Estrogen. Eric Vittinghoff has included themes like Hormone therapy and Gynecology in his Estrogen study.
His scientific interests lie mostly in Internal medicine, Cardiology, Cohort, Confidence interval and Randomized controlled trial. His study in Hazard ratio, Atrial fibrillation, Heart failure, Odds ratio and Blood pressure is carried out as part of his Internal medicine studies. His Cardiology research is multidisciplinary, incorporating elements of Diastole and Autopsy.
His Cohort study combines topics from a wide range of disciplines, such as Body mass index, Cohort study, Diabetes mellitus, Type 2 diabetes and Retrospective cohort study. His research in Body mass index intersects with topics in Young adult, Logistic regression and Obesity, Weight loss. The concepts of his Randomized controlled trial study are interwoven with issues in Psychological intervention, Physical therapy and Men who have sex with men.
His primary areas of study are Internal medicine, Randomized controlled trial, Body mass index, Confidence interval and Cohort. Many of his studies on Internal medicine apply to Cardiology as well. His Randomized controlled trial research is multidisciplinary, relying on both Psychological intervention, Placebo, Men who have sex with men and MEDLINE.
His research integrates issues of Longitudinal study, Logistic regression, Obesity, Weight loss and Urology in his study of Body mass index. His Confidence interval research is multidisciplinary, incorporating perspectives in Intervention, Cardiovascular health, Primary care, Family medicine and Emergency medicine. He has researched Cohort in several fields, including Cohort study, Survival rate, Retrospective cohort study, Stroke and Disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Stephen Hulley;Deborah Grady;Trudy Bush;Curt Furberg.
JAMA (1998)
Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression
Eric Vittinghoff;Charles E. McCulloch.
American Journal of Epidemiology (2007)
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene
Michael Dean;Mary Carrington;Cheryl Winkler;Gavin A. Huttley.
Science (1996)
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)
Stephen Hulley;Curt Furberg;Elizabeth Barrett-Connor;Jane Cauley.
JAMA (2002)
Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models
Eric Vittinghoff;David V. Glidden;Stephen C. Shiboski;Charles E. McCulloch.
(2006)
Subclinical hypothyroidism and the risk of coronary heart disease and mortality.
Nicolas Rodondi;Wendy P. J. den Elzen;Douglas C. Bauer;Anne R. Cappola.
JAMA (2010)
Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression
Michael W. Smith;Michael Dean;Mary Carrington;Cheryl Winkler.
Science (1997)
Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease
Mary A. Whooley;Peter de Jonge;Eric Vittinghoff;Christian Otte.
JAMA (2008)
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
Brett Ley;Christopher J. Ryerson;Eric Vittinghoff;Jay H. Ryu.
Annals of Internal Medicine (2012)
Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study
Deborah Grady;Nanette K. Wenger;David Herrington;Steven Khan.
Annals of Internal Medicine (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
Wake Forest University
University of California, San Francisco
University of California, San Francisco
Lawrence Livermore National Laboratory
Fraunhofer Institute for Intelligent Analysis and Information Systems
University of Pennsylvania
Jožef Stefan Institute
Delft University of Technology
Seoul National University
United States Department of Agriculture
Université Laval
University of California, Irvine
United States Naval Research Laboratory
European Centre for Medium-Range Weather Forecasts
Royal Prince Alfred Hospital
University of Arkansas for Medical Sciences
The University of Texas MD Anderson Cancer Center
California Institute of Technology
National Aeronautics and Space Administration